Sign inGet started

Kavanaugh William Michael

Insider CIK 1578767 · FPRX SVP & Chief Scientific Officer · CTMX Chief Scientific Officer and

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CTMX CytomX Therapeutics, Inc. A Award deriv2020-02-142020-02-19120,000— $0120,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2019-01-252019-01-2990,000— $090,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2018-01-242018-01-2675,000— $075,000SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise deriv2017-12-082017-12-125,130— $0240,912SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise2017-12-082017-12-125,130$1.57 $8.1K19,047SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise deriv2017-10-042017-10-0648,368— $048,368SEC↗
CTMX CytomX Therapeutics, Inc. S Sale2017-10-042017-10-0648,368$24.34 $1.18M13,917SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise2017-10-042017-10-0648,368$4.47 $216.2K62,285SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2017-04-142017-04-1748,368— $096,736SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2017-01-252017-01-27120,000— $0120,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2016-09-262016-09-2848,368— $048,368SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2016-01-212016-01-2580,000— $080,000SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise deriv2015-12-312015-12-318,917— $076,688SEC↗
CTMX CytomX Therapeutics, Inc. M Exercise2015-12-312015-12-318,917$6.61 $58.9K13,917SEC↗
CTMX CytomX Therapeutics, Inc. P Buy2015-10-142015-10-165,000$12.00 $60.0K5,000SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2015-08-262015-10-1685,605— $085,605SEC↗
CTMX CytomX Therapeutics, Inc. A Award deriv2015-05-072015-10-16246,042— $0246,042SEC↗
FPRX FIVE PRIME THERAPEUTICS IN A Award deriv2014-08-222014-08-2615,000— $015,000SEC↗